Contribution of different pneumococcal virulence factors to experimental meningitis in mice

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Ricci, Susanna ^a   Gerlini, Alice ^a   Pammolli, Andrea ^a   Chiavolini, Damiana ^a,d   Braione, Velia ^a,e   Tripodi, Sergio A ^b   Colombari, Bruna ^c   Blasi, Elisabetta ^c   Oggioni, Marco R ^a   Peppoloni, Samuele ^c   Pozzi, Gianni ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Sanofi Aventis SpA   (Italy)

Author keywords

Capsule; Experimental pneumococcal meningitis; Microglia; PspA; PspC

Indexed keywords

PNEUMOCOCCAL SURFACE PROTEIN A; PNEUMOCOCCAL SURFACE PROTEIN C; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CAPSULE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BRAIN DAMAGE; BRAIN TISSUE; CONTROLLED STUDY; ENCEPHALITIS; FEMALE; HISTOPATHOLOGY; HOST PATHOGEN INTERACTION; INNATE IMMUNITY; MICROGLIA; MOLECULAR PATHOLOGY; MOUSE; NERVE CELL LESION; NONHUMAN; PHAGOCYTOSIS; PNEUMOCOCCAL MENINGITIS; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE; VIRUS REPLICATION;

ANIMALS; BACTERIAL CAPSULES; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MENINGITIS, PNEUMOCOCCAL; MICE; STREPTOCOCCUS PNEUMONIAE; VIRULENCE FACTORS;

EID: 84884475644     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-444     Document Type: Article

References (59)

1. Kadioglu A, Weiser JN, Paton JC, Andrew PW. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 2008, 6:288-301.
2. Mitchell AM, Mitchell TJ. Streptococcus pneumoniae: virulence factors and variation. Clin Microbiol Infect 2010, 16:411-418.
3. Brown EJ, Joiner KA, Cole RM, Berger M. Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule. Infect Immun 1983, 39:403-409.
4. Abeyta M, Hardy GG, Yother J. Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae. Infect Immun 2003, 71:218-225.
5. Hyams C, Camberlein E, Cohen JM, Bax K, Brown JS. The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms. Infect Immun 2010, 78:704-715.
6. Tu AH, Fulgham RL, McCrory MA, Briles DE, Szalai AJ. Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae. Infect Immun 1999, 67:4720-4724.
7. Ren B, McCrory MA, Pass C, Bullard DC, Ballantyne CM, Xu Y, Briles DE, Szalai AJ. The virulence function of Streptococcus pneumoniae surface protein A involves inhibition of complement activation and impairment of complement receptor-mediated protection. J Immunol 2004, 173:7506-7512.
8. Ren B, Szalai A, Hollingshead SK, Briles DE. Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface. Infect Immun 2004, 72:114-122.
9. Mukerji R, Mirza S, Roche AM, Widener RW, Croney CM, Rhee DK, Weiser JN, Szalai AJ, Briles DE. Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine. J Immunol 2012, 189:5327-5335.
10. Hammerschmidt S, Bethe G, Remane PH, Chhatwal GS. Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae. Infect Immun 1999, 67:1683-1687.
11. Dave S, Carmicle S, Hammerschmidt S, Pangburn MK, Mc Daniel LS. Dual roles of PspC, a surface protein of Streptococcus pneumoniae, in binding human secretory IgA and factor H. J Immunol 2004, 173:471-477.
12. Hammerschmidt S, Tilling MP, Wolff S, Vaerman JP, Chhatwal GS. Species-specific binding of human secretory component to SpsA protein of Streptococcus pneumonie via a hexapeptide motif. Mol Microbiol 2000, 36:726-736.
13. Zhang JR, Mostov KE, Nanno M, Shimida S, Ohwaki M, Tuomanen E. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 2000, 102:827-837.
14. Elm C, Braathen R, Bergmann S, Frank R, Vaerman JP, Kaetzel CS, Chhatwal GS, Johansen FE, Hammerschmidt S. Ectodomains 3 and 4 of human polymeric Immunoglobulin receptor (hpIgR) mediate invasion of Streptococcus pneumoniae into the epithelium. J Biol Chem 2004, 279:6296-6304.
15. Smith BL, Hostetter MK. C3 as substrate for adhesion of Streptococcus pneumoniae. J Infect Dis 2000, 182:497-508.
16. Janulczyk R, Iannelli F, Sjöholm AG, Pozzi G, Björck L. Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function. J Biol Chem 2000, 275:37257-37263.
17. Jarva H, Janulczyk R, Hellwage J, Zipfel PF, Björck L, Meri S. Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H. J Immunol 2002, 168:1886-1894.
18. Duthy TG, Ormsby RJ, Giannakis E, Ogunniyi DA, Stroeher UH, Paton JC, Gordon DL. The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15. Infect Immun 2002, 70:5604-5611.
19. Mook-Kanamori BB, Geldhoff M, van der Poll T, van de Beek D. Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev 2011, 24:557-591.
20. Koedel U, Klein M, Pfister HW. New understandings on the pathophysiology of bacterial meningitis. Curr Opin Infect Dis 2010, 23:217-223.
21. Gerber J, Nau R. Mechanisms of injury in bacterial meningitis. Curr Opin Neurol 2010, 23:312-318.
22. Klein M, Obermaier B, Angele B, Pfister HW, Wagner H, Koedel U, Kirschning CJ. Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4. J Infect Dis 2008, 198:1028-1036.
23. Tuomanen E, Tomasz A, Hengstler B, Zak O. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J Infect Dis 1985, 151:535-540.
24. Tuomanen E, Liu H, Hengstler B, Zak O, Tomasz A. The induction of meningeal inflammation by components of the pneumococcal cell wall. J Infect Dis 1985, 151:859-868.
25. Hirst RA, Sikand KS, Rutman A, Mitchell TJ, Andrew PW, O'Callaghan C. Relative roles of pneumolysin and hydrogen peroxide from Streptococcus pneumoniae in inhibition of ependymal ciliary beat frequency. Infect Immun 2000, 68:1557-1562.
26. Zysk G, Schneider-Wald BK, Hwang JH, Bejo L, Kim KS, Mitchell TJ, Hakenbeck R, Heinz HP. Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae. Infect Immun 2001, 69:845-852.
27. Braun JS, Sublett JE, Freyer D, Mitchell TJ, Cleveland JL, Tuomanen EI, Weber JR. Pneumococcal pneumolysin and H2O2 mediate brain cell apoptosis during meningitis. J Clin Invest 2002, 109:19-27.
28. Winter AJ, Comis SD, Osborne MP, Tarlow MJ, Stephen J, Andrew PW, Hill J, Mitchell TJ. A role for pneumolysin but not neuraminidase in the hearing loss and cochlear damage induced by experimental pneumococcal meningitis in guinea pigs. Infect Immun 1997, 65:4411-4418.
29. Wellmer A, Zysk G, Gerber J, Kunst T, von Mering M, Bunkowski S, Eiffert H, Nau R. Decreased virulence of a pneumolysin-deficient strain of Streptococcus pneumoniae in murine meningitis. Infect Immun 2002, 70:6504-6508.
30. Pracht D, Elm C, Gerber G, Bergmann S, Rohde M, Seiler M, Kim KS, Jenkinson HF, Nau R, Hammerschmidt S. PavA of Streptococcus pneumoniae modulates adherence, invasion, and meningeal inflammation. Infect Immun 2005, 73:2680-2689.
31. Vilhardt F. Microglia: phagocyte and glia cell. Int J Biochem Cell Biol 2005, 37:17-21.
32. Hauwel M, Furon E, Canova C, Griffiths M, Neal J, Gasque P. Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, " protective" glial stem cells and stromal ependymal cells. Brain Res Rev 2005, 48:220-233.
33. Rock RB, Gekker G, Hu S, Sheng WS, Cheeran M, Lokensgard JR, Peterson PK. Role of microglia in central nervous system infections. Clin Microbiol Rev 2004, 17:942-964.
34. Horton RM, Cai Z, Ho SN, Pease LR. Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. Biotechniques 1990, 8:528-535.
35. Ali F, Lee ME, Iannelli F, Pozzi G, Mitchell TJ, Read RC, Dockrell DH. Streptococcus pneumoniae-associated human macrophage apoptosis after bacterial internalization via complement and Fcgamma receptors correlates with intracellular bacterial load. J Infect Dis 2003, 188:1119-1131.
36. Iannelli F, Chiavolini D, Ricci S, Oggioni MR, Pozzi G. Pneumococcal surface protein C contributes to sepsis caused by Streptococcus pneumoniae in mice. Infect Immun 2004, 72:3077-3080.
37. Pearce BJ, Iannelli F, Pozzi G. Construction of new unencapsulated (rough) strains of Streptococcus pneumoniae. Res Microbiol 2002, 153:243-247.
38. Oggioni MR, Memmi G, Maggi T, Chiavolini D, Iannelli F, Pozzi G. Pneumococcal zinc metalloproteinase ZmpC cleaves human matrix metalloproteinase 9 and is a virulence factor in experimental pneumonia. Mol Microbiol 2003, 49:795-805.
39. Chiavolini D, Tripodi S, Parigi R, Oggioni MR, Blasi E, Cintorino M, Pozzi G, Ricci S. Method for inducing experimental pneumococcal meningitis in outbred mice. BMC Microbiol 2004, 4:36.
40. Sandgren A, Albiger B, Orihuela CJ, Tuomanen E, Normark S, Henriques-Normark B. Virulence in mice of pneumococcal clonal types with known invasive disease potential in humans. J Infect Dis 2005, 192:791-800.
41. Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol 1990, 27:229-237.
42. Peppoloni S, Ricci S, Orsi CF, Colombari B, De Santi MM, Messinò M, Fabio G, Zanardi A, Righi E, Braione V, et al. The encapsulated strain TIGR4 of Streptococcus pneumoniae is phagocytosed but is resistant to intracellular killing by mouse microglia. Microbes Infect 2010, 12:990-1001.
43. Peppoloni S, Colombari B, Beninati C, Felici F, Teti G, Speziale P, Ricci S, Ardizzoni A, Manca L, Blasi E. The Spr1875 protein confers resistance to the microglia-mediated killing of Streptococcus pneumoniae. Microb Pathog 2013, 59-60:42-47.
44. Efron B, Tibshirani RJ. An introduction to the Bootstrap 1994, New York: Chapman and Hall.
45. McDaniel LS, Yother J, Vijayakumar MN, McGarry L, Guild WR, Briles DE. Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA). J Exp Med 1987, 165:381-394.
46. Berry AM, Paton JC. Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect Immun 2000, 68:133-140.
47. Yuste J, Botto M, Paton JC, Holden DW, Brown JS. Additive inhibition of complement deposition by pneumolysin and PspA facilitates Streptococcus pneumoniae septicemia. J Immunol 2005, 175:1813-1819.
48. Quin LR, Moore QC, McDaniel LS. Pneumolysin, PspA, and PspC contribute to pneumococcal evasion of early innate immune responses during bacteremia in mice. Infect Immun 2007, 75:2067-2070.
49. Ogunniyi DA, Giammarinaro P, Paton JC. The genes encoding virulence-associated proteins and the capsule of Streptococcus pneumoniae are upregulated and differentially expressed in vivo. Microbiology 2002, 148:2045-2053.
50. Orihuela CJ, Gao G, Francis KP, Yu J, Tuomanen EI. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis 2004, 190:1661-1669.
51. Orihuela CJ, Mahdavi J, Thornton J, Mann B, Wooldridge KG, Abouseada N, Oldfield NJ, Self T, Ala'Aldeen DA, Tuomanen EI. Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models. J Clin Invest 2009, 119:1638-1646.
52. Ring A, Weiser JN, Tuomanen EI. Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J Clin Invest 1998, 102:347-360.
53. Peppoloni S, Colombari B, Neglia R, Quaglino D, Iannelli F, Oggioni MR, Pozzi G, Blasi E. The lack of pneumococcal surface protein C (PspC) increases the susceptibility of Streptococcus pneumoniae to the killing by microglia. Med Microbiol Immunol 2006, 195:21-28.
54. Kerr AR, Paterson GK, McCluskey J, Iannelli F, Oggioni MR, Pozzi G, Mitchell TJ. The contribution of PspC to pneumococcal virulence varies between strains and is accomplished by both complement evasion and complement-independent mechanisms. Infect Immun 2006, 74:5319-5324.
55. Griffith F. The significance of pneumococcal types. J Hyg 1928, 27:113-159.
56. Austrian R. Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. Rev Infect Dis 1981, 3:S1-S17.
57. Tomasz A, Saukkonen K. The nature of cell wall-derived inflammatory components of pneumococci. Pediatr Infect Dis 1989, 8:902-903.
58. Weber JR, Moreillon P, Tuomanen EI. Innate sensors for Gram-positive bacteria. Curr Opin Immunol 2003, 15:408-415.
59. Moreillon P, Majcherczyk PA. Proinflammatory activity of cell-wall constituents from Gram-positive bacteria. Scand J Infect Dis 2003, 35:632-641.